

Most Read This Week
- Semaglutide and Cardiovascular Outcomes in Patients With Obesity Without Diabetes
- Apixaban for Stroke Prevention in Patients With Subclinical Atrial Fibrillation
- 10-Year CVD Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus
- Anticoagulation With Edoxaban in Patients With Long Atrial High-Rate Episodes
- Dapagliflozin in Patients With Myocardial Infarction Without Diabetes or Heart Failure
Recently Updated
- DOACs for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation
- Stroke and Bleeding Risk in Patients With Atrial Fibrillation and a CHA2DS2-VASc Risk Score of 1
- Clinical Outcomes of Tongxinluo Therapy in Patients With Acute Myocardial Infarction
- Impacts of Gestational Weight Gain Seen 50+ Years Later
- Filtration of Traffic-Related Air Pollution Mitigates Its Impact on BP